Alphatec Holdings, Inc.

ATEC Healthcare Medical Devices

Alphatec Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $764.2 million, up 25.0% from fiscal 2024. In the quarter to June 2026, revenue grew 15.1%, EPS grew 40.7%, free cash flow fell 146.9% and total debt fell 7.79%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.

10.45 0.48 −4.39%
Market cap
$1.7B
P/E
0.0×
Fwd P/E
−16.4×
Dividend yield
—
F-score
6/9
Altman Z
0.89
Beneish M
−3.43
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
6 6 6 6

+8 more TTM periods

ROE
(1,879.90%) 274.65% 16,450.51% (3,055.22%)
ROA
(13.91%) (15.82%) (18.30%) (20.21%)
ROIC
(8.10%) (10.41%) (14.54%) (14.61%)
Return on Tangible Assets
(31.40%) (35.41%) (39.06%) (43.38%)
Average Days of Receivables
49.32 49.33 46.48 48.55
Free Cash Flow per Share
(0.04) (0.01) (0.03) (0.02)
Free Cash Flow
(5.74) (0.78) (4.41) (3.35)
Other line items

Show all line items

Columns are period end dates